nodes	percent_of_prediction	percent_of_DWPC	metapath
Furosemide—PGD—Dacarbazine—sarcoma	0.553	0.711	CbGbCtD
Furosemide—SLC22A5—Dactinomycin—sarcoma	0.101	0.13	CbGbCtD
Furosemide—ABCC2—Vincristine—sarcoma	0.0485	0.0624	CbGbCtD
Furosemide—ABCC2—Etoposide—sarcoma	0.0444	0.0571	CbGbCtD
Furosemide—ABCC2—Doxorubicin—sarcoma	0.0303	0.039	CbGbCtD
Furosemide—SLC12A1—appendage—sarcoma	0.00463	0.0662	CbGeAlD
Furosemide—CA2—periosteum—sarcoma	0.00338	0.0484	CbGeAlD
Furosemide—PGD—mammary gland—sarcoma	0.00185	0.0265	CbGeAlD
Furosemide—CA5B—mammary gland—sarcoma	0.00176	0.0251	CbGeAlD
Furosemide—CA14—seminal vesicle—sarcoma	0.00161	0.023	CbGeAlD
Furosemide—SLCO2A1—myometrium—sarcoma	0.00148	0.0211	CbGeAlD
Furosemide—CA5A—liver—sarcoma	0.00143	0.0204	CbGeAlD
Furosemide—SLC12A1—hematopoietic system—sarcoma	0.00137	0.0196	CbGeAlD
Furosemide—ALB—mammary gland—sarcoma	0.00136	0.0195	CbGeAlD
Furosemide—SLCO2A1—seminal vesicle—sarcoma	0.00133	0.0191	CbGeAlD
Furosemide—PGD—myometrium—sarcoma	0.00131	0.0188	CbGeAlD
Furosemide—PGD—seminal vesicle—sarcoma	0.00119	0.017	CbGeAlD
Furosemide—CA14—cardiac atrium—sarcoma	0.00116	0.0166	CbGeAlD
Furosemide—CA12—connective tissue—sarcoma	0.00115	0.0164	CbGeAlD
Furosemide—PGD—hematopoietic system—sarcoma	0.00113	0.0162	CbGeAlD
Furosemide—SLCO2A1—skin of body—sarcoma	0.0011	0.0158	CbGeAlD
Furosemide—PGD—connective tissue—sarcoma	0.00109	0.0156	CbGeAlD
Furosemide—CA5B—hematopoietic system—sarcoma	0.00107	0.0153	CbGeAlD
Furosemide—CA9—tendon—sarcoma	0.00107	0.0153	CbGeAlD
Furosemide—CA14—tendon—sarcoma	0.00101	0.0145	CbGeAlD
Furosemide—PGD—smooth muscle tissue—sarcoma	0.000994	0.0142	CbGeAlD
Furosemide—SLC22A5—mammary gland—sarcoma	0.000988	0.0141	CbGeAlD
Furosemide—PGD—skin of body—sarcoma	0.000982	0.014	CbGeAlD
Furosemide—SLCO2A1—cardiac atrium—sarcoma	0.000962	0.0138	CbGeAlD
Furosemide—SLCO2A1—uterus—sarcoma	0.000957	0.0137	CbGeAlD
Furosemide—CA1—hematopoietic system—sarcoma	0.000944	0.0135	CbGeAlD
Furosemide—CA9—testis—sarcoma	0.000883	0.0126	CbGeAlD
Furosemide—PGD—cardiac atrium—sarcoma	0.000857	0.0123	CbGeAlD
Furosemide—PGD—uterus—sarcoma	0.000853	0.0122	CbGeAlD
Furosemide—SLCO2A1—tendon—sarcoma	0.000838	0.012	CbGeAlD
Furosemide—CA5B—cardiac atrium—sarcoma	0.000812	0.0116	CbGeAlD
Furosemide—SLC22A8—hematopoietic system—sarcoma	0.000797	0.0114	CbGeAlD
Furosemide—PGD—lymphoid tissue—sarcoma	0.000795	0.0114	CbGeAlD
Furosemide—CA14—liver—sarcoma	0.000792	0.0113	CbGeAlD
Furosemide—CA4—seminal vesicle—sarcoma	0.000777	0.0111	CbGeAlD
Furosemide—SLC12A1—testis—sarcoma	0.000752	0.0108	CbGeAlD
Furosemide—PGD—tendon—sarcoma	0.000747	0.0107	CbGeAlD
Furosemide—SLC22A11—liver—sarcoma	0.000732	0.0105	CbGeAlD
Furosemide—PGD—bone marrow—sarcoma	0.000724	0.0104	CbGeAlD
Furosemide—CA5B—tendon—sarcoma	0.000708	0.0101	CbGeAlD
Furosemide—SLC22A5—myometrium—sarcoma	0.000701	0.01	CbGeAlD
Furosemide—SLCO2A1—testis—sarcoma	0.000694	0.00993	CbGeAlD
Furosemide—CA2—embryo—sarcoma	0.000686	0.00981	CbGeAlD
Furosemide—CA1—lymphoid tissue—sarcoma	0.000665	0.00951	CbGeAlD
Furosemide—SLCO2A1—liver—sarcoma	0.000656	0.00939	CbGeAlD
Furosemide—CA2—seminal vesicle—sarcoma	0.000644	0.00921	CbGeAlD
Furosemide—SLC22A5—seminal vesicle—sarcoma	0.000634	0.00906	CbGeAlD
Furosemide—PGD—testis—sarcoma	0.000619	0.00885	CbGeAlD
Furosemide—CA2—hematopoietic system—sarcoma	0.000612	0.00876	CbGeAlD
Furosemide—CA1—bone marrow—sarcoma	0.000605	0.00866	CbGeAlD
Furosemide—CA2—connective tissue—sarcoma	0.000589	0.00843	CbGeAlD
Furosemide—CA5B—testis—sarcoma	0.000586	0.00838	CbGeAlD
Furosemide—PGD—liver—sarcoma	0.000585	0.00837	CbGeAlD
Furosemide—CA4—cardiac atrium—sarcoma	0.000561	0.00802	CbGeAlD
Furosemide—CA2—smooth muscle tissue—sarcoma	0.000539	0.00771	CbGeAlD
Furosemide—CA2—skin of body—sarcoma	0.000532	0.00761	CbGeAlD
Furosemide—SLC22A5—skin of body—sarcoma	0.000524	0.00749	CbGeAlD
Furosemide—ABCC2—tendon—sarcoma	0.000514	0.00736	CbGeAlD
Furosemide—SLCO2A1—lymph node—sarcoma	0.000503	0.0072	CbGeAlD
Furosemide—CA1—liver—sarcoma	0.000489	0.007	CbGeAlD
Furosemide—CA4—tendon—sarcoma	0.000489	0.00699	CbGeAlD
Furosemide—CA4—bone marrow—sarcoma	0.000473	0.00677	CbGeAlD
Furosemide—CA2—cardiac atrium—sarcoma	0.000465	0.00665	CbGeAlD
Furosemide—SLC22A5—cardiac atrium—sarcoma	0.000457	0.00654	CbGeAlD
Furosemide—ALB—testis—sarcoma	0.000455	0.0065	CbGeAlD
Furosemide—PGD—lymph node—sarcoma	0.000448	0.00642	CbGeAlD
Furosemide—CA2—lymphoid tissue—sarcoma	0.000431	0.00617	CbGeAlD
Furosemide—ALB—liver—sarcoma	0.00043	0.00615	CbGeAlD
Furosemide—ABCC2—testis—sarcoma	0.000426	0.00609	CbGeAlD
Furosemide—CA5B—lymph node—sarcoma	0.000425	0.00608	CbGeAlD
Furosemide—CA2—tendon—sarcoma	0.000405	0.0058	CbGeAlD
Furosemide—CA4—testis—sarcoma	0.000405	0.00579	CbGeAlD
Furosemide—ABCC2—liver—sarcoma	0.000403	0.00576	CbGeAlD
Furosemide—SLC22A5—tendon—sarcoma	0.000399	0.0057	CbGeAlD
Furosemide—CA2—bone marrow—sarcoma	0.000392	0.00561	CbGeAlD
Furosemide—CA1—lymph node—sarcoma	0.000375	0.00537	CbGeAlD
Furosemide—CA2—testis—sarcoma	0.000335	0.0048	CbGeAlD
Furosemide—SLC22A5—testis—sarcoma	0.00033	0.00472	CbGeAlD
Furosemide—ALB—lymph node—sarcoma	0.00033	0.00471	CbGeAlD
Furosemide—CA2—liver—sarcoma	0.000317	0.00454	CbGeAlD
Furosemide—SLC22A5—liver—sarcoma	0.000312	0.00446	CbGeAlD
Furosemide—Thrombocytopenia—Mitoxantrone—sarcoma	0.000311	0.00203	CcSEcCtD
Furosemide—Anorexia—Vincristine—sarcoma	0.000311	0.00203	CcSEcCtD
Furosemide—Skin disorder—Mitoxantrone—sarcoma	0.000309	0.00202	CcSEcCtD
Furosemide—ABCC2—lymph node—sarcoma	0.000309	0.00442	CbGeAlD
Furosemide—Lethargy—Epirubicin—sarcoma	0.000308	0.00201	CcSEcCtD
Furosemide—Hyperhidrosis—Mitoxantrone—sarcoma	0.000307	0.00201	CcSEcCtD
Furosemide—Hypotension—Vincristine—sarcoma	0.000305	0.00199	CcSEcCtD
Furosemide—Feeling abnormal—Thiotepa—sarcoma	0.000304	0.00198	CcSEcCtD
Furosemide—Anorexia—Mitoxantrone—sarcoma	0.000303	0.00198	CcSEcCtD
Furosemide—Hyponatraemia—Epirubicin—sarcoma	0.000303	0.00198	CcSEcCtD
Furosemide—Feeling abnormal—Dactinomycin—sarcoma	0.000301	0.00197	CcSEcCtD
Furosemide—Gastrointestinal pain—Thiotepa—sarcoma	0.000301	0.00197	CcSEcCtD
Furosemide—Anaemia—Etoposide—sarcoma	0.0003	0.00196	CcSEcCtD
Furosemide—Gastrointestinal pain—Dactinomycin—sarcoma	0.000299	0.00195	CcSEcCtD
Furosemide—Hypotension—Mitoxantrone—sarcoma	0.000297	0.00194	CcSEcCtD
Furosemide—Dermatitis exfoliative—Doxorubicin—sarcoma	0.000296	0.00193	CcSEcCtD
Furosemide—Paraesthesia—Vincristine—sarcoma	0.000293	0.00192	CcSEcCtD
Furosemide—CA4—lymph node—sarcoma	0.000293	0.0042	CbGeAlD
Furosemide—Urticaria—Thiotepa—sarcoma	0.000293	0.00191	CcSEcCtD
Furosemide—Dermatitis bullous—Doxorubicin—sarcoma	0.000292	0.00191	CcSEcCtD
Furosemide—Vertigo—Etoposide—sarcoma	0.000291	0.0019	CcSEcCtD
Furosemide—Abdominal pain—Thiotepa—sarcoma	0.000291	0.0019	CcSEcCtD
Furosemide—Body temperature increased—Thiotepa—sarcoma	0.000291	0.0019	CcSEcCtD
Furosemide—Leukopenia—Etoposide—sarcoma	0.00029	0.0019	CcSEcCtD
Furosemide—Purpura—Doxorubicin—sarcoma	0.00029	0.00189	CcSEcCtD
Furosemide—Abdominal pain—Dactinomycin—sarcoma	0.000289	0.00189	CcSEcCtD
Furosemide—Body temperature increased—Dactinomycin—sarcoma	0.000289	0.00189	CcSEcCtD
Furosemide—Anaphylactoid reaction—Doxorubicin—sarcoma	0.000288	0.00188	CcSEcCtD
Furosemide—Paraesthesia—Mitoxantrone—sarcoma	0.000286	0.00187	CcSEcCtD
Furosemide—Lethargy—Doxorubicin—sarcoma	0.000285	0.00186	CcSEcCtD
Furosemide—Decreased appetite—Vincristine—sarcoma	0.000284	0.00185	CcSEcCtD
Furosemide—Somnolence—Mitoxantrone—sarcoma	0.000283	0.00185	CcSEcCtD
Furosemide—Blood creatinine increased—Epirubicin—sarcoma	0.000283	0.00185	CcSEcCtD
Furosemide—Gastrointestinal disorder—Vincristine—sarcoma	0.000282	0.00184	CcSEcCtD
Furosemide—Fatigue—Vincristine—sarcoma	0.000282	0.00184	CcSEcCtD
Furosemide—Dehydration—Epirubicin—sarcoma	0.000281	0.00183	CcSEcCtD
Furosemide—Hyponatraemia—Doxorubicin—sarcoma	0.00028	0.00183	CcSEcCtD
Furosemide—Pain—Vincristine—sarcoma	0.000279	0.00182	CcSEcCtD
Furosemide—Constipation—Vincristine—sarcoma	0.000279	0.00182	CcSEcCtD
Furosemide—Decreased appetite—Mitoxantrone—sarcoma	0.000276	0.00181	CcSEcCtD
Furosemide—Orthostatic hypotension—Epirubicin—sarcoma	0.000276	0.0018	CcSEcCtD
Furosemide—Hypokalaemia—Epirubicin—sarcoma	0.000275	0.00179	CcSEcCtD
Furosemide—Fatigue—Mitoxantrone—sarcoma	0.000274	0.00179	CcSEcCtD
Furosemide—Unspecified disorder of skin and subcutaneous tissue—Etoposide—sarcoma	0.000274	0.00179	CcSEcCtD
Furosemide—Pain—Mitoxantrone—sarcoma	0.000272	0.00178	CcSEcCtD
Furosemide—Constipation—Mitoxantrone—sarcoma	0.000272	0.00178	CcSEcCtD
Furosemide—Toxic epidermal necrolysis—Epirubicin—sarcoma	0.000272	0.00178	CcSEcCtD
Furosemide—Hypersensitivity—Thiotepa—sarcoma	0.000271	0.00177	CcSEcCtD
Furosemide—Hypersensitivity—Dactinomycin—sarcoma	0.000269	0.00176	CcSEcCtD
Furosemide—Gastrointestinal pain—Vincristine—sarcoma	0.000267	0.00174	CcSEcCtD
Furosemide—Confusional state—Etoposide—sarcoma	0.000267	0.00174	CcSEcCtD
Furosemide—Muscular weakness—Epirubicin—sarcoma	0.000266	0.00174	CcSEcCtD
Furosemide—Anaphylactic shock—Etoposide—sarcoma	0.000265	0.00173	CcSEcCtD
Furosemide—Asthenia—Thiotepa—sarcoma	0.000264	0.00173	CcSEcCtD
Furosemide—Abdominal distension—Epirubicin—sarcoma	0.000263	0.00172	CcSEcCtD
Furosemide—Asthenia—Dactinomycin—sarcoma	0.000262	0.00171	CcSEcCtD
Furosemide—Feeling abnormal—Mitoxantrone—sarcoma	0.000262	0.00171	CcSEcCtD
Furosemide—Blood creatinine increased—Doxorubicin—sarcoma	0.000262	0.00171	CcSEcCtD
Furosemide—Pruritus—Thiotepa—sarcoma	0.000261	0.0017	CcSEcCtD
Furosemide—Gastrointestinal pain—Mitoxantrone—sarcoma	0.00026	0.0017	CcSEcCtD
Furosemide—Dehydration—Doxorubicin—sarcoma	0.00026	0.0017	CcSEcCtD
Furosemide—Thrombocytopenia—Etoposide—sarcoma	0.000259	0.00169	CcSEcCtD
Furosemide—Eosinophilia—Epirubicin—sarcoma	0.000258	0.00169	CcSEcCtD
Furosemide—Body temperature increased—Vincristine—sarcoma	0.000258	0.00169	CcSEcCtD
Furosemide—Abdominal pain—Vincristine—sarcoma	0.000258	0.00169	CcSEcCtD
Furosemide—Skin disorder—Etoposide—sarcoma	0.000257	0.00168	CcSEcCtD
Furosemide—Hyperhidrosis—Etoposide—sarcoma	0.000256	0.00167	CcSEcCtD
Furosemide—Pancreatitis—Epirubicin—sarcoma	0.000256	0.00167	CcSEcCtD
Furosemide—Orthostatic hypotension—Doxorubicin—sarcoma	0.000255	0.00167	CcSEcCtD
Furosemide—Hypokalaemia—Doxorubicin—sarcoma	0.000254	0.00166	CcSEcCtD
Furosemide—Urticaria—Mitoxantrone—sarcoma	0.000253	0.00165	CcSEcCtD
Furosemide—Anorexia—Etoposide—sarcoma	0.000252	0.00165	CcSEcCtD
Furosemide—Diarrhoea—Thiotepa—sarcoma	0.000252	0.00165	CcSEcCtD
Furosemide—Body temperature increased—Mitoxantrone—sarcoma	0.000251	0.00164	CcSEcCtD
Furosemide—Abdominal pain—Mitoxantrone—sarcoma	0.000251	0.00164	CcSEcCtD
Furosemide—Toxic epidermal necrolysis—Doxorubicin—sarcoma	0.000251	0.00164	CcSEcCtD
Furosemide—Diarrhoea—Dactinomycin—sarcoma	0.00025	0.00163	CcSEcCtD
Furosemide—Hypotension—Etoposide—sarcoma	0.000247	0.00162	CcSEcCtD
Furosemide—Muscular weakness—Doxorubicin—sarcoma	0.000246	0.00161	CcSEcCtD
Furosemide—Dizziness—Thiotepa—sarcoma	0.000244	0.00159	CcSEcCtD
Furosemide—CA2—lymph node—sarcoma	0.000243	0.00348	CbGeAlD
Furosemide—Abdominal distension—Doxorubicin—sarcoma	0.000243	0.00159	CcSEcCtD
Furosemide—Pollakiuria—Epirubicin—sarcoma	0.000241	0.00157	CcSEcCtD
Furosemide—Hypersensitivity—Vincristine—sarcoma	0.000241	0.00157	CcSEcCtD
Furosemide—SLC22A5—lymph node—sarcoma	0.000239	0.00342	CbGeAlD
Furosemide—Eosinophilia—Doxorubicin—sarcoma	0.000239	0.00156	CcSEcCtD
Furosemide—Photosensitivity reaction—Epirubicin—sarcoma	0.000238	0.00156	CcSEcCtD
Furosemide—Paraesthesia—Etoposide—sarcoma	0.000238	0.00155	CcSEcCtD
Furosemide—Pancreatitis—Doxorubicin—sarcoma	0.000237	0.00155	CcSEcCtD
Furosemide—Hyperglycaemia—Epirubicin—sarcoma	0.000235	0.00154	CcSEcCtD
Furosemide—Somnolence—Etoposide—sarcoma	0.000235	0.00154	CcSEcCtD
Furosemide—Hypersensitivity—Mitoxantrone—sarcoma	0.000234	0.00153	CcSEcCtD
Furosemide—Asthenia—Vincristine—sarcoma	0.000234	0.00153	CcSEcCtD
Furosemide—Vomiting—Thiotepa—sarcoma	0.000234	0.00153	CcSEcCtD
Furosemide—Drowsiness—Epirubicin—sarcoma	0.000233	0.00152	CcSEcCtD
Furosemide—Vomiting—Dactinomycin—sarcoma	0.000232	0.00152	CcSEcCtD
Furosemide—Rash—Thiotepa—sarcoma	0.000232	0.00152	CcSEcCtD
Furosemide—Dermatitis—Thiotepa—sarcoma	0.000232	0.00152	CcSEcCtD
Furosemide—Headache—Thiotepa—sarcoma	0.000231	0.00151	CcSEcCtD
Furosemide—Stevens-Johnson syndrome—Epirubicin—sarcoma	0.000231	0.00151	CcSEcCtD
Furosemide—Rash—Dactinomycin—sarcoma	0.00023	0.00151	CcSEcCtD
Furosemide—Decreased appetite—Etoposide—sarcoma	0.00023	0.0015	CcSEcCtD
Furosemide—Renal failure—Epirubicin—sarcoma	0.000229	0.00149	CcSEcCtD
Furosemide—Gastrointestinal disorder—Etoposide—sarcoma	0.000228	0.00149	CcSEcCtD
Furosemide—Asthenia—Mitoxantrone—sarcoma	0.000228	0.00149	CcSEcCtD
Furosemide—Fatigue—Etoposide—sarcoma	0.000228	0.00149	CcSEcCtD
Furosemide—Constipation—Etoposide—sarcoma	0.000226	0.00148	CcSEcCtD
Furosemide—Pain—Etoposide—sarcoma	0.000226	0.00148	CcSEcCtD
Furosemide—Diarrhoea—Vincristine—sarcoma	0.000223	0.00146	CcSEcCtD
Furosemide—Sweating—Epirubicin—sarcoma	0.000223	0.00146	CcSEcCtD
Furosemide—Pollakiuria—Doxorubicin—sarcoma	0.000223	0.00146	CcSEcCtD
Furosemide—Photosensitivity reaction—Doxorubicin—sarcoma	0.00022	0.00144	CcSEcCtD
Furosemide—Hepatobiliary disease—Epirubicin—sarcoma	0.00022	0.00144	CcSEcCtD
Furosemide—Nausea—Thiotepa—sarcoma	0.000219	0.00143	CcSEcCtD
Furosemide—Feeling abnormal—Etoposide—sarcoma	0.000218	0.00142	CcSEcCtD
Furosemide—Hyperglycaemia—Doxorubicin—sarcoma	0.000218	0.00142	CcSEcCtD
Furosemide—Diarrhoea—Mitoxantrone—sarcoma	0.000218	0.00142	CcSEcCtD
Furosemide—Nausea—Dactinomycin—sarcoma	0.000217	0.00142	CcSEcCtD
Furosemide—Agranulocytosis—Epirubicin—sarcoma	0.000217	0.00142	CcSEcCtD
Furosemide—Gastrointestinal pain—Etoposide—sarcoma	0.000216	0.00141	CcSEcCtD
Furosemide—Dizziness—Vincristine—sarcoma	0.000216	0.00141	CcSEcCtD
Furosemide—Drowsiness—Doxorubicin—sarcoma	0.000215	0.00141	CcSEcCtD
Furosemide—Stevens-Johnson syndrome—Doxorubicin—sarcoma	0.000213	0.00139	CcSEcCtD
Furosemide—Renal failure—Doxorubicin—sarcoma	0.000211	0.00138	CcSEcCtD
Furosemide—Urticaria—Etoposide—sarcoma	0.00021	0.00137	CcSEcCtD
Furosemide—Abdominal pain—Etoposide—sarcoma	0.000209	0.00137	CcSEcCtD
Furosemide—Body temperature increased—Etoposide—sarcoma	0.000209	0.00137	CcSEcCtD
Furosemide—Vomiting—Vincristine—sarcoma	0.000208	0.00136	CcSEcCtD
Furosemide—Sweating—Doxorubicin—sarcoma	0.000206	0.00135	CcSEcCtD
Furosemide—Urinary tract disorder—Epirubicin—sarcoma	0.000206	0.00135	CcSEcCtD
Furosemide—Rash—Vincristine—sarcoma	0.000206	0.00135	CcSEcCtD
Furosemide—Dermatitis—Vincristine—sarcoma	0.000206	0.00134	CcSEcCtD
Furosemide—Urethral disorder—Epirubicin—sarcoma	0.000205	0.00134	CcSEcCtD
Furosemide—Headache—Vincristine—sarcoma	0.000205	0.00134	CcSEcCtD
Furosemide—Hepatobiliary disease—Doxorubicin—sarcoma	0.000203	0.00133	CcSEcCtD
Furosemide—Vomiting—Mitoxantrone—sarcoma	0.000202	0.00132	CcSEcCtD
Furosemide—Visual impairment—Epirubicin—sarcoma	0.000201	0.00131	CcSEcCtD
Furosemide—Agranulocytosis—Doxorubicin—sarcoma	0.000201	0.00131	CcSEcCtD
Furosemide—Rash—Mitoxantrone—sarcoma	0.000201	0.00131	CcSEcCtD
Furosemide—Dermatitis—Mitoxantrone—sarcoma	0.0002	0.00131	CcSEcCtD
Furosemide—Headache—Mitoxantrone—sarcoma	0.000199	0.0013	CcSEcCtD
Furosemide—Erythema multiforme—Epirubicin—sarcoma	0.000197	0.00129	CcSEcCtD
Furosemide—Eye disorder—Epirubicin—sarcoma	0.000195	0.00127	CcSEcCtD
Furosemide—Hypersensitivity—Etoposide—sarcoma	0.000195	0.00127	CcSEcCtD
Furosemide—Tinnitus—Epirubicin—sarcoma	0.000195	0.00127	CcSEcCtD
Furosemide—Nausea—Vincristine—sarcoma	0.000194	0.00127	CcSEcCtD
Furosemide—Urinary tract disorder—Doxorubicin—sarcoma	0.000191	0.00125	CcSEcCtD
Furosemide—Asthenia—Etoposide—sarcoma	0.00019	0.00124	CcSEcCtD
Furosemide—Angiopathy—Epirubicin—sarcoma	0.000189	0.00124	CcSEcCtD
Furosemide—Urethral disorder—Doxorubicin—sarcoma	0.000189	0.00124	CcSEcCtD
Furosemide—Nausea—Mitoxantrone—sarcoma	0.000189	0.00123	CcSEcCtD
Furosemide—Immune system disorder—Epirubicin—sarcoma	0.000189	0.00123	CcSEcCtD
Furosemide—Pruritus—Etoposide—sarcoma	0.000187	0.00122	CcSEcCtD
Furosemide—Arrhythmia—Epirubicin—sarcoma	0.000186	0.00122	CcSEcCtD
Furosemide—Visual impairment—Doxorubicin—sarcoma	0.000186	0.00122	CcSEcCtD
Furosemide—Erythema multiforme—Doxorubicin—sarcoma	0.000183	0.00119	CcSEcCtD
Furosemide—Malnutrition—Epirubicin—sarcoma	0.000182	0.00119	CcSEcCtD
Furosemide—Erythema—Epirubicin—sarcoma	0.000182	0.00119	CcSEcCtD
Furosemide—Diarrhoea—Etoposide—sarcoma	0.000181	0.00118	CcSEcCtD
Furosemide—Eye disorder—Doxorubicin—sarcoma	0.000181	0.00118	CcSEcCtD
Furosemide—Tinnitus—Doxorubicin—sarcoma	0.00018	0.00118	CcSEcCtD
Furosemide—Flatulence—Epirubicin—sarcoma	0.000179	0.00117	CcSEcCtD
Furosemide—Dysgeusia—Epirubicin—sarcoma	0.000178	0.00116	CcSEcCtD
Furosemide—Angiopathy—Doxorubicin—sarcoma	0.000175	0.00114	CcSEcCtD
Furosemide—Dizziness—Etoposide—sarcoma	0.000175	0.00114	CcSEcCtD
Furosemide—Muscle spasms—Epirubicin—sarcoma	0.000175	0.00114	CcSEcCtD
Furosemide—Immune system disorder—Doxorubicin—sarcoma	0.000174	0.00114	CcSEcCtD
Furosemide—Arrhythmia—Doxorubicin—sarcoma	0.000173	0.00113	CcSEcCtD
Furosemide—Vision blurred—Epirubicin—sarcoma	0.000171	0.00112	CcSEcCtD
Furosemide—Vomiting—Etoposide—sarcoma	0.000168	0.0011	CcSEcCtD
Furosemide—Erythema—Doxorubicin—sarcoma	0.000168	0.0011	CcSEcCtD
Furosemide—Malnutrition—Doxorubicin—sarcoma	0.000168	0.0011	CcSEcCtD
Furosemide—Anaemia—Epirubicin—sarcoma	0.000168	0.0011	CcSEcCtD
Furosemide—Agitation—Epirubicin—sarcoma	0.000167	0.00109	CcSEcCtD
Furosemide—Rash—Etoposide—sarcoma	0.000167	0.00109	CcSEcCtD
Furosemide—Dermatitis—Etoposide—sarcoma	0.000167	0.00109	CcSEcCtD
Furosemide—Headache—Etoposide—sarcoma	0.000166	0.00108	CcSEcCtD
Furosemide—Flatulence—Doxorubicin—sarcoma	0.000166	0.00108	CcSEcCtD
Furosemide—Dysgeusia—Doxorubicin—sarcoma	0.000165	0.00108	CcSEcCtD
Furosemide—Vertigo—Epirubicin—sarcoma	0.000163	0.00107	CcSEcCtD
Furosemide—Leukopenia—Epirubicin—sarcoma	0.000163	0.00106	CcSEcCtD
Furosemide—Muscle spasms—Doxorubicin—sarcoma	0.000162	0.00106	CcSEcCtD
Furosemide—Vision blurred—Doxorubicin—sarcoma	0.000158	0.00104	CcSEcCtD
Furosemide—Nausea—Etoposide—sarcoma	0.000157	0.00103	CcSEcCtD
Furosemide—Anaemia—Doxorubicin—sarcoma	0.000155	0.00102	CcSEcCtD
Furosemide—Agitation—Doxorubicin—sarcoma	0.000155	0.00101	CcSEcCtD
Furosemide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	0.000154	0.001	CcSEcCtD
Furosemide—Dry mouth—Epirubicin—sarcoma	0.000151	0.000988	CcSEcCtD
Furosemide—Vertigo—Doxorubicin—sarcoma	0.000151	0.000987	CcSEcCtD
Furosemide—Leukopenia—Doxorubicin—sarcoma	0.000151	0.000983	CcSEcCtD
Furosemide—Confusional state—Epirubicin—sarcoma	0.00015	0.000977	CcSEcCtD
Furosemide—Anaphylactic shock—Epirubicin—sarcoma	0.000148	0.000969	CcSEcCtD
Furosemide—Shock—Epirubicin—sarcoma	0.000146	0.000953	CcSEcCtD
Furosemide—Nervous system disorder—Epirubicin—sarcoma	0.000145	0.00095	CcSEcCtD
Furosemide—Thrombocytopenia—Epirubicin—sarcoma	0.000145	0.000949	CcSEcCtD
Furosemide—Skin disorder—Epirubicin—sarcoma	0.000144	0.000941	CcSEcCtD
Furosemide—Hyperhidrosis—Epirubicin—sarcoma	0.000143	0.000937	CcSEcCtD
Furosemide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	0.000142	0.000929	CcSEcCtD
Furosemide—Anorexia—Epirubicin—sarcoma	0.000141	0.000924	CcSEcCtD
Furosemide—Dry mouth—Doxorubicin—sarcoma	0.00014	0.000915	CcSEcCtD
Furosemide—Hypotension—Epirubicin—sarcoma	0.000139	0.000905	CcSEcCtD
Furosemide—Confusional state—Doxorubicin—sarcoma	0.000138	0.000904	CcSEcCtD
Furosemide—Anaphylactic shock—Doxorubicin—sarcoma	0.000137	0.000896	CcSEcCtD
Furosemide—Shock—Doxorubicin—sarcoma	0.000135	0.000882	CcSEcCtD
Furosemide—Nervous system disorder—Doxorubicin—sarcoma	0.000135	0.000879	CcSEcCtD
Furosemide—Thrombocytopenia—Doxorubicin—sarcoma	0.000134	0.000878	CcSEcCtD
Furosemide—Skin disorder—Doxorubicin—sarcoma	0.000133	0.000871	CcSEcCtD
Furosemide—Paraesthesia—Epirubicin—sarcoma	0.000133	0.00087	CcSEcCtD
Furosemide—Hyperhidrosis—Doxorubicin—sarcoma	0.000133	0.000867	CcSEcCtD
Furosemide—Somnolence—Epirubicin—sarcoma	0.000132	0.000861	CcSEcCtD
Furosemide—Anorexia—Doxorubicin—sarcoma	0.000131	0.000854	CcSEcCtD
Furosemide—Decreased appetite—Epirubicin—sarcoma	0.000129	0.000842	CcSEcCtD
Furosemide—Hypotension—Doxorubicin—sarcoma	0.000128	0.000838	CcSEcCtD
Furosemide—Gastrointestinal disorder—Epirubicin—sarcoma	0.000128	0.000836	CcSEcCtD
Furosemide—Fatigue—Epirubicin—sarcoma	0.000128	0.000835	CcSEcCtD
Furosemide—Constipation—Epirubicin—sarcoma	0.000127	0.000828	CcSEcCtD
Furosemide—Pain—Epirubicin—sarcoma	0.000127	0.000828	CcSEcCtD
Furosemide—Paraesthesia—Doxorubicin—sarcoma	0.000123	0.000805	CcSEcCtD
Furosemide—Feeling abnormal—Epirubicin—sarcoma	0.000122	0.000798	CcSEcCtD
Furosemide—Somnolence—Doxorubicin—sarcoma	0.000122	0.000797	CcSEcCtD
Furosemide—Gastrointestinal pain—Epirubicin—sarcoma	0.000121	0.000792	CcSEcCtD
Furosemide—Decreased appetite—Doxorubicin—sarcoma	0.000119	0.000779	CcSEcCtD
Furosemide—Gastrointestinal disorder—Doxorubicin—sarcoma	0.000118	0.000774	CcSEcCtD
Furosemide—Fatigue—Doxorubicin—sarcoma	0.000118	0.000773	CcSEcCtD
Furosemide—Urticaria—Epirubicin—sarcoma	0.000118	0.00077	CcSEcCtD
Furosemide—Constipation—Doxorubicin—sarcoma	0.000117	0.000767	CcSEcCtD
Furosemide—Pain—Doxorubicin—sarcoma	0.000117	0.000767	CcSEcCtD
Furosemide—Body temperature increased—Epirubicin—sarcoma	0.000117	0.000766	CcSEcCtD
Furosemide—Abdominal pain—Epirubicin—sarcoma	0.000117	0.000766	CcSEcCtD
Furosemide—Feeling abnormal—Doxorubicin—sarcoma	0.000113	0.000739	CcSEcCtD
Furosemide—Gastrointestinal pain—Doxorubicin—sarcoma	0.000112	0.000733	CcSEcCtD
Furosemide—Hypersensitivity—Epirubicin—sarcoma	0.000109	0.000714	CcSEcCtD
Furosemide—Urticaria—Doxorubicin—sarcoma	0.000109	0.000712	CcSEcCtD
Furosemide—Abdominal pain—Doxorubicin—sarcoma	0.000108	0.000709	CcSEcCtD
Furosemide—Body temperature increased—Doxorubicin—sarcoma	0.000108	0.000709	CcSEcCtD
Furosemide—Asthenia—Epirubicin—sarcoma	0.000106	0.000695	CcSEcCtD
Furosemide—Pruritus—Epirubicin—sarcoma	0.000105	0.000685	CcSEcCtD
Furosemide—Diarrhoea—Epirubicin—sarcoma	0.000101	0.000663	CcSEcCtD
Furosemide—Hypersensitivity—Doxorubicin—sarcoma	0.000101	0.00066	CcSEcCtD
Furosemide—Asthenia—Doxorubicin—sarcoma	9.85e-05	0.000643	CcSEcCtD
Furosemide—Dizziness—Epirubicin—sarcoma	9.81e-05	0.000641	CcSEcCtD
Furosemide—Pruritus—Doxorubicin—sarcoma	9.71e-05	0.000634	CcSEcCtD
Furosemide—Vomiting—Epirubicin—sarcoma	9.43e-05	0.000616	CcSEcCtD
Furosemide—Diarrhoea—Doxorubicin—sarcoma	9.39e-05	0.000613	CcSEcCtD
Furosemide—Rash—Epirubicin—sarcoma	9.35e-05	0.000611	CcSEcCtD
Furosemide—Dermatitis—Epirubicin—sarcoma	9.34e-05	0.00061	CcSEcCtD
Furosemide—Headache—Epirubicin—sarcoma	9.29e-05	0.000607	CcSEcCtD
Furosemide—Dizziness—Doxorubicin—sarcoma	9.07e-05	0.000593	CcSEcCtD
Furosemide—Nausea—Epirubicin—sarcoma	8.81e-05	0.000575	CcSEcCtD
Furosemide—Vomiting—Doxorubicin—sarcoma	8.72e-05	0.00057	CcSEcCtD
Furosemide—Rash—Doxorubicin—sarcoma	8.65e-05	0.000565	CcSEcCtD
Furosemide—Dermatitis—Doxorubicin—sarcoma	8.64e-05	0.000565	CcSEcCtD
Furosemide—Headache—Doxorubicin—sarcoma	8.6e-05	0.000562	CcSEcCtD
Furosemide—Nausea—Doxorubicin—sarcoma	8.15e-05	0.000532	CcSEcCtD
